Myelitis  >>  Flebogamma 5% DIF (human immune globulin intravenous 5%)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Flebogamma 5% DIF (human immune globulin intravenous 5%) / Grifols
NCT00160082: Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)

Completed
N/A
124
Europe
Xepol
Calliditas Therapeutics AB
Post Polio Syndrome, PPS
 
05/03

Download Options